"Prostate cancer is a worldwide problem. It is the most common cancer in men, with clear racial disparities,” said researcher ...

Metastatic castration-resistant prostate is an advanced form of the cancer that’s incurable. Learn about treatment options ...

The hope is the therapy can effectively target cancerous cells at relatively small doses while minimizing side effects.

Scientists at the University of Michigan Rogel Cancer Center have found a promising new way to fight one of the most ...

Prostate cancer has distinct genetic properties in different groups of men that can be targeted to improve patient outcomes, ...

At AUA 2025, experts will present on novel bladder cancer therapies, advanced renal cell carcinoma comparisons, frailty in ...

Insights from AUA 2025, including anticipated presentations, key takeaways, and how new research in metastatic prostate ...

Nubeqa plus hormone therapy improved outcomes in metastatic prostate cancer, reducing disease progression and showing a ...

The phase 2a LEGION-100 trial seeks to evaluate the safety and effectiveness of the SYNC-T/SV-102 combination therapy for treating metastatic castration-resistant prostate cancer (mCRPC) and to ...

The treatment of prostate cancer in Uganda follows similar principles to those used worldwide, including surgery, radiation ...

Metastatic castration-resistant prostate cancer causes urinary symptoms, fatigue, pain, and more. This article covers the ...

The treatment of metastatic castration-resistant prostate cancer ... With appropriate treatment, people with this advanced ...